Revilab Peptide ML 05 — for respiratory system

Revilab ML 05 is a new-generation medication for the prevention and treatment of bronchopulmonary diseases. It rejuvenates the body, strengthens the immune system, and enhances the body’s reserve capacity. Revilab ML 05 is a comprehensive formulation based on several ultrashort peptides. These are bioregulators of cellular (T-cell) immunity, the bronchi, lungs, and stomach.

T-cell immunity peptides increase the quantity and quality of immune cells and regulate the functioning of the immune system.

Bronchial and lung peptides activate tissue regeneration in these organs, improving their metabolism and detoxification. As a result, respiratory function normalizes, the bronchopulmonary system’s resistance to infections increases, and recovery from respiratory diseases is accelerated. In addition, lung peptides restore the gastric mucosa, promoting the healing of ulcers and the treatment of gastritis.

Revilab ML 05 also contains biologically active substances and vitamins that have a beneficial effect on the immune system, bronchi, and lungs. The components are selected based on the principle of synergy—in a complex formulation, the beneficial substances begin to act faster and more effectively than each one individually.

It is not a medication and is used in conjunction with primary treatment.

Indications:
 

• Prevention of bronchopulmonary diseases;

• Elderly and senile age;

• Smoking, work involving the inhalation of dust and harmful substances, living in damp and cold climates, or in areas with poor environmental conditions;

• Hereditary predisposition to bronchopulmonary diseases;

• Weakened immune system;

• periods of acute respiratory viral infections (including coronavirus infection);

• acute and chronic bronchopulmonary diseases (tracheitis, bronchitis, pneumonia, bronchial asthma, pulmonary emphysema, etc.).